InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,127.79
(
1.26%
)
US TECH 100
17,446.00
(
2.17%
)
Dow Jones
38,675.68
(
1.18%
)
Brent Oil
83.04
(
-0.11%
)
Bitcoin
63,865.53
(
-0.21%
)
Post# of 689192
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

moneyfrog

Send PM Follow Ignore
Followers 2
Posts 43
Boards Moderated 0
Alias Born 02/28/2015

moneyfrog

Re: Rkmatters post# 30035

Saturday, 02/28/2015 6:17:53 PM

Saturday, February 28, 2015 6:17:53 PM

Post# of 689192
Thanks RK,
Does that mean it will be quicker too get approvals on colorectal and lung by first getting it on sarcoma and pancreatic and then getting extensions? If not than I hope one of the other promising immunotherapies do not beat NWBO to it.(Obviously, it would be great for those suffering from the disease whichever gets there fist). Looking at the market numbers I would hope whichever path gets to NWBO to CRC approval first would be the smartest,(provided it effective for CRC).
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote
Recent NWBO News
More NWBO News
InvestorsHub NewsWire

NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM

ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM

Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM

Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM

Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM

Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM

Start posting your company's news
Only $200 per official company press release!